Atlas Trials

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Clinical trial NCT04454580 · UNKNOWN

Trial details

NCT number
NCT04454580
Sponsor
Ospedale Maggiore Di Trieste
Status
UNKNOWN
Study type
OBSERVATIONAL
Acute Myeloid Leukemia, AdultHypomethylating AgentsVenetoclax
Start date
2020-08-01
Primary completion
2020-09-16
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.